Xtant Medical Holdings, Inc.
XTNTNYSECIK 1453593HealthcareFiscal year ends Dec 31
Reports and events: 545 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-08-1016:32 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-027585 |
| 2023-08-0909:04 ET | 8-K | 8.01 Other events | 0001493152-23-027280 |
| 2023-08-0316:59 ET | SC 13D/A | Ownership report, active investor, amended | 0000947871-23-000815 |
| 2023-08-0107:20 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001493152-23-026162 |
| 2023-08-0107:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-026160 |
| 2023-07-2816:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-025869 |
| 2023-07-2809:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-23-025769 |
| 2023-07-1116:25 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-23-024228 |
| 2023-07-0308:28 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-023229 |
| 2023-06-2008:58 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-23-021783 |
| 2023-06-0818:00 ET | DEF 14A | Proxy statementPeriod 2023-06-07 | 0001493152-23-020490 |
| 2023-05-1916:15 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-23-018330 |
| 2023-05-1808:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-018040 |
| 2023-05-1616:15 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001493152-23-017793 |
| 2023-05-0511:14 ET | SC 13D/A | Ownership report, active investor, amended | 0000947871-23-000526 |
| 2023-05-0407:20 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001493152-23-015374 |
| 2023-05-0407:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-015373 |
| 2023-05-0407:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-23-015371 |
| 2023-03-0707:30 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001493152-23-006881 |
| 2023-03-0707:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-006880 |
| 2023-03-0116:15 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-006396 |
| 2023-02-0109:00 ET | 8-K | 8.01 Other events | 0001493152-23-003251 |
| 2023-01-0908:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-000906 |
| 2022-11-0307:15 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001493152-22-030284 |
| 2022-11-0307:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-22-030277 |
| 2022-10-2816:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-22-029849 |
| 2022-10-1108:15 ET | 8-K | 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-028040 |
| 2022-09-2006:30 ET | DEF 14A | Proxy statementPeriod 2022-09-20 | 0001493152-22-026308 |
| 2022-09-0614:19 ET | SC 13D | Ownership report, active investor | 0001104659-22-097801 |
| 2022-08-3108:15 ET | 8-K | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-22-024444 |
| 2022-08-3016:37 ET | SC 13D/A | Ownership report, active investor, amended | 0000947871-22-000940 |
| 2022-08-2408:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-22-023900 |
| 2022-08-0407:20 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001493152-22-021237 |
| 2022-08-0407:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-22-021233 |
| 2022-05-0508:16 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001493152-22-012170 |
| 2022-05-0508:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-22-012168 |
| 2022-05-0208:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-22-011719 |
| 2022-03-0807:15 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001493152-22-006240 |
| 2022-03-0807:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-22-006238 |
| 2022-01-0308:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-000042 |
| 2021-11-1207:30 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001493152-21-028011 |
| 2021-11-1207:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-21-028005 |
| 2021-08-0507:31 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001493152-21-018670 |
| 2021-08-0507:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-21-018666 |
| 2021-07-2806:45 ET | 8-K | 5.07 Shareholder vote results | 0001493152-21-017923 |
| 2021-06-1408:00 ET | DEF 14A | Proxy statementPeriod 2021-06-14 | 0001493152-21-014227 |
| 2021-05-2008:44 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-21-012322 |
| 2021-05-1107:30 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001493152-21-010949 |
| 2021-05-1107:15 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-010948 |
| 2021-05-0616:15 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-21-010620 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.